Advocacy Actions
Meeting with the DG Trade and DG Agri
On 18th Mar, representatives of the PN Desk were invited to a briefing meeting with officers from DG Trade and DG Agri to discuss the difficulties the industry has encountered and the key concerns the Desk wanted to address to the Chinese authorities.
Read moreMeeting with the Legislative Standing Committee of the National People’s Congress (NPC)
On 17th Mar, representatives of the PN Desk had a meeting with the NPC on the Food Safety Law. During the discussion, the representatives addressed their concerns on the latest draft Food Safety Law and discussed the updates of the revision progress of the Food Safety Law.
Read moreMeeting with the Chinese Academy of Inspection and Quarantine (CAIQ)
On 17th Mar, representatives of the PN Desk met with the chief engineer of the CAIQ to discuss the testing methods of whey protein.
Read moreMeeting with the China Food and Drug Administration
On 17th Mar, representatives of the PN Desk met with the CFDA regarding the Oko-test Report.
Lobby Letter on Circular 62 to the State Council and the Ministry of Finance
The Finance & Taxation Working Group addressed a lobby letter to the Ministry of Finance and to the State Council (copy to MOFCOM) regarding the uncertainty created by the inconsistent implementation of Circular 62 on the clean-up of local preferential tax policies.
Read moreNew Year celebration host by Jiangsu CCPIT
On March 6th, European Chamber Nanjing Chapter attended the Meeting of Exchange between Foreign Institutions and Jiangsu Chamber of International Commerce, the meeting was hosted by Jiangsu CCPIT and Jiangsu Chamber of International Commerce.
Read moreLobby Letter to the NHFPC
The Cheese Industry Desk submitted a lobby letter to the NHFPC to address the revision of the National Food Safety Standards on Cheese and Processed Cheese.
Read moreIntroduction meeting by Department of Registration on their 2015 Yearly Plan
CFDA organised a meeting with the industry to introduce their 2015 yearly working plan and priorities in terms of regulation reform and implementation.
Read moreCFDA: Provisions on "Qualification of Medical Institutions to Conduct Clinical Trials"
Draft Regulations by the CFDA which conditions hospitals (or equivalent medical institutions) must fulfill to be qualified to conduct clinical trials for medical devices.
Read morePresentation of the Project on the Re-evaluation of the max. Level of Nutrients in Infant and Young Children Formula
On 13th Feb, the PN Desk invited Ms. Junhua Han to give a presentation about project the Re-evaluation of the max. Level of Nutrients in Infant and Young Children Formula.
Read more